XML 62 R50.htm IDEA: XBRL DOCUMENT v3.25.3
Concentration of Credit Risk and Current Expected Credit Losses - Narrative (Details) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2025
Dec. 31, 2024
Concentration of risk    
Allowance for doubtful accounts $ 0 $ 0
Novartis and Lilly | Accounts Receivable | Credit Concentration Risk    
Concentration of risk    
Percentage of concentration risk 20.00% 19.00%
Customer A, B, C, D, E and F | Accounts Receivable | Credit Concentration Risk    
Concentration of risk    
Percentage of concentration risk 59.00% 54.00%